Fulgent Genetics, Inc. (FLGT) Analyst Estimates Annual - Discounting Cash Flows
Fulgent Genetics, Inc.
FLGT (NASDAQ)
Period Ending: 2027
12-31
2026
12-31
2025
12-31
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
Number of Analysts 3 3 2 2 2 1 1 1 1 1 1 1
Estimated Revenue
Low 375.9 340.2 299.5 279.6 278.3 595.8 912.7 319.1 31.94 21.07 19.14 18.03
Average 375.9 343.2 310.7 282 278.4 610.8 933 326.2 32.65 21.54 19.57 18.43
High 375.9 345.9 321.9 284.4 278.4 629 958.2 335 33.53 22.12 20.1 18.93
Estimated EBITDA
Low 106.1 96.02 84.55 78.93 78.57 378.2 502.1 96.72 9.68 -3.26 -10.04 5.47
Average 106.1 96.88 87.7 79.6 78.58 472.8 627.6 98.87 9.9 -2.71 -7.96 5.59
High 106.1 97.63 90.86 80.27 78.59 567.3 753.1 101.5 10.16 -2.17 -5.88 5.74
Estimated EBIT
Low 86.86 78.6 69.21 64.61 64.31 359 488.1 79.67 7.97 -5.04 -13.7 4.5
Average 86.86 79.3 71.79 65.15 64.33 448.8 610.1 81.45 8.15 -4.2 -11.32 4.6
High 86.86 79.92 74.37 65.7 64.33 538.6 732.1 83.64 8.37 -3.36 -8.95 4.73
Estimated Net Income
Low -12.41 -22.68 -83.39 8.94 -201.4 269.3 368.5 181.1 3.3 -6.01 -10.35 9.48
Average -11.67 -17.26 -16.68 9.69 -167.8 336.6 460.6 186.4 3.4 -5 -8.53 9.75
High -10.93 -11.85 50.03 10.44 -134.3 403.9 552.7 192.9 3.51 -4 -6.71 10.09
Estimated SGA Expenses
Low 96.18 87.04 76.64 71.55 98.3 84.77 52.82 77.81 7.79 7.4 4.67 4.4
Average 96.18 87.82 79.5 72.15 122.9 106 66.03 79.54 7.96 9.25 4.77 4.49
High 96.18 88.5 82.36 72.76 147.5 127.2 79.23 81.68 8.18 11.09 4.9 4.62
Estimated EPS
Low -0.411 -0.75 -2.76 0.296 -1.05 5.43 15.24 6.08 0.111 -0.098 0.003 0.318
Average -0.386 -0.627 -0.552 0.325 -0.976 5.61 15.68 6.26 0.114 -0.095 0.003 0.327
High -0.361 -0.392 1.65 0.345 -0.907 5.83 16.23 6.48 0.118 -0.092 0.003 0.339
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us